Literature DB >> 17000740

Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.

Jane R Schwebke1, Frank J Barrientes.   

Abstract

Clinical isolates of Trichomonas vaginalis were obtained from women consecutively enrolled in a study of partner notification. Testing of susceptibility to metronidazole and tinidazole was performed. Resistance to metronidazole and tinidazole was present in 17/178 (9.6%) and 1/178 (0.56%) strains, respectively. In vitro resistance was poorly correlated with clinical response to treatment.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17000740      PMCID： PMC1693974          DOI： 10.1128/AAC.00814-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Metronidazole-resistant vaginal trichomoniasis--an emerging problem.

Authors:  J D Sobel; V Nagappan; P Nyirjesy
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

2.  Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.

Authors:  S Pérez; A Fernández-Verdugo; F Pérez; F Vázquez
Journal:  Sex Transm Dis       Date:  2001-02       Impact factor: 2.830

3.  In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis.

Authors:  Andrea L Crowell; Kolby A Sanders-Lewis; W Evan Secor
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

4.  Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.

Authors:  G Schmid; E Narcisi; D Mosure; W E Secor; J Higgins; H Moreno
Journal:  J Reprod Med       Date:  2001-06       Impact factor: 0.142

5.  Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.

Authors:  M Laga; A Manoka; M Kivuvu; B Malele; M Tuliza; N Nzila; J Goeman; F Behets; V Batter; M Alary
Journal:  AIDS       Date:  1993-01       Impact factor: 4.177

6.  Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group.

Authors:  M F Cotch; J G Pastorek; R P Nugent; S L Hillier; R S Gibbs; D H Martin; D A Eschenbach; R Edelman; J C Carey; J A Regan; M A Krohn; M A Klebanoff; A V Rao; G G Rhoads
Journal:  Sex Transm Dis       Date:  1997-07       Impact factor: 2.830

7.  Strain of Trichomonas vaginalis resistant to metronidazole and other 5-nitroimidazoles.

Authors:  J G Meingassner; J Thurner
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

8.  Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial.

Authors:  Matthew A Price; Dickman Zimba; Irving F Hoffman; S Cornelia Kaydos-Daniels; William C Miller; Francis Martinson; David Chilongozi; Ester Kip; Esnath Msowoya; Marcia M Hobbs; Peter N Kazembe; Myron S Cohen
Journal:  Sex Transm Dis       Date:  2003-06       Impact factor: 2.830

9.  In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.

Authors:  J G Lossick; M Müller; T E Gorrell
Journal:  J Infect Dis       Date:  1986-05       Impact factor: 5.226

10.  In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.

Authors:  M Müller; J G Lossick; T E Gorrell
Journal:  Sex Transm Dis       Date:  1988 Jan-Mar       Impact factor: 2.830
  10 in total
  54 in total

1.  Effect of the antimicrobial peptide tritrpticin on the in vitro viability and growth of Trichomonas vaginalis.

Authors:  Veronica V Infante; Alma D Miranda-Olvera; Luis M De Leon-Rodriguez; Fernando Anaya-Velazquez; Mayra C Rodriguez; Eva E Avila
Journal:  Curr Microbiol       Date:  2010-07-17       Impact factor: 2.188

2.  Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women.

Authors:  Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2010-08       Impact factor: 2.830

3.  A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.

Authors:  Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12-15       Impact factor: 3.731

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

5.  The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.

Authors:  Aida A Abdel-Magied; El-Said I El-Kholya; Salwa M Abou El-Khair; Eman S Abdelmegeed; Marwa M Hamoudaa; Sara A Mohamed; Nora Labeeb El-Tantawy
Journal:  Parasitol Res       Date:  2017-09-27       Impact factor: 2.289

6.  Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and Brazil.

Authors:  Heidi E Jones; Sheri A Lippman; Helio H Caiaffa-Filho; Taryn Young; Janneke H H M van de Wijgert
Journal:  J Clin Microbiol       Date:  2013-01-16       Impact factor: 5.948

Review 7.  Natural and synthetic compound anti-Trichomonas vaginalis: an update review.

Authors:  Patrícia de Brum Vieira; Raquel Brandt Giordani; Alexandre José Macedo; Tiana Tasca
Journal:  Parasitol Res       Date:  2015-02-18       Impact factor: 2.289

8.  Anti-Trichomonas vaginalis activity of ursolic acid derivative: a promising alternative.

Authors:  Fernanda Gobbi Bitencourt; Patrícia de Brum Vieira; Lucia Collares Meirelles; Graziela Vargas Rigo; Elenilson Figueiredo da Silva; Simone Cristina Baggio Gnoatto; Tiana Tasca
Journal:  Parasitol Res       Date:  2018-03-23       Impact factor: 2.289

9.  In Vitro Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole.

Authors:  Arindam P Ghosh; Cheri Aycock; Jane R Schwebke
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

10.  Trichomonas vaginalis metronidazole resistance is associated with single nucleotide polymorphisms in the nitroreductase genes ntr4Tv and ntr6Tv.

Authors:  Teresa E Paulish-Miller; Peter Augostini; Jessica A Schuyler; William L Smith; Eli Mordechai; Martin E Adelson; Scott E Gygax; William E Secor; David W Hilbert
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.